It’s hard to imagine a baseball game without peanuts, but in a new collaboration between Minor League Baseball and AUVI-Q (epinephrine injection, USP), fans that suffer from peanut allergies can enjoy America’s national pastime with less concern.
The New Orleans Baby Cakes will host a “Peanut-Free Game Day” on Thursday, August 24 when they face the Colorado Springs Sky Sox. To make the ballpark safer to sufferers of peanut allergies, the peanut free-game will feature no in-park sales of peanuts or products containing peanut ingredients.
As one of the most common food allergies, peanut sensitivity can lead to reactions ranging from mild irritation to anaphylactic shock, with peanut allergies becoming more prevalent in children.
“With peanut allergies on the rise, AUVI-Q will support our overarching commitment to our fans,” said David Wright, Chief Marketing & Commercial Officer for Minor League Baseball. “We hope that all families, regardless of existing allergies, can experience a Minor League Baseball game to its fullest during designated peanut-free nights.”
“We’re proud to support MiLB to help provide a safer environment for those who suffer from severe peanut allergies to enjoy one of our nation’s favorite pastimes,” said Dr. Eric Edwards, a life-threatening allergy sufferer and co-inventor of AUVI-Q. “AUVI-Q is committed to providing information and resources to help educate the public about life-threatening allergies and encourage a community of inclusion and acceptance.”
AUVI-Q is an FDA-approved prescription medicine used to treat life-threatening allergic reactions, including anaphylaxis, in people who are at risk for or have a history of serious allergic reactions. AUVI-Q is the first and only EAI with an auto-retractable needle and includes innovative features such as voice instructions. AUVI-Q is not a substitute for emergency medical treatment.